exjade
(deferasirox)Novartis Pharmaceuticals Corporation
Usage: Exjade is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.